These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 8234831
1. Myocardial salvage efficacy of a thromboxane receptor antagonist, SQ, 30,741, in relation to inhibition ex vivo of platelet function in the ferret. Gomoll AW, Ogletree ML. Prostaglandins; 1993 Sep; 46(3):233-42. PubMed ID: 8234831 [Abstract] [Full Text] [Related]
2. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion. Grover GJ, Schumacher WA, Simon M, Parham C. J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089 [Abstract] [Full Text] [Related]
3. Direct myocardial effects of the thromboxane A2/prostaglandin H2 agonists U-46619 and SQ 26,655 under ischemic and nonischemic conditions. Grover GJ, Hedberg A, Ogletree ML. Pharmacology; 1990 Dec; 41(1):1-15. PubMed ID: 2122481 [Abstract] [Full Text] [Related]
4. Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogs. Grover GJ, Schumacher WA. J Cardiovasc Pharmacol; 1988 Jan; 11(1):29-35. PubMed ID: 2450253 [Abstract] [Full Text] [Related]
5. Dose-related cardioprotection by ifetroban in relation to inhibition of thrombosis and ex vivo platelet function. Gomoll AW, Schumacher WA, Ogletree ML. Pharmacology; 1995 Feb; 50(2):92-110. PubMed ID: 7716179 [Abstract] [Full Text] [Related]
11. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM, Wu TS, Teng CM. Br J Pharmacol; 1994 Mar 19; 111(3):906-12. PubMed ID: 8019768 [Abstract] [Full Text] [Related]
12. The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemia. Grover GJ, Schumacher WA. Basic Res Cardiol; 1989 Mar 19; 84(1):103-10. PubMed ID: 2522297 [Abstract] [Full Text] [Related]
16. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha. Krauss AH, Woodward DF, Gibson LL, Protzman CE, Williams LS, Burk RM, Gac TS, Roof MB, Abbas F, Marshall K, Senior J. Br J Pharmacol; 1996 Mar 19; 117(6):1171-80. PubMed ID: 8882612 [Abstract] [Full Text] [Related]
17. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets. Ohkubo S, Nakahata N, Ohizumi Y. Br J Pharmacol; 1996 Mar 19; 117(6):1095-104. PubMed ID: 8882602 [Abstract] [Full Text] [Related]
19. A ferret model of electrical-induction of arterial thrombosis that is sensitive to aspirin. Schumacher WA, Steinbacher TE, Megill JR, Durham SK. J Pharmacol Toxicol Methods; 1996 Feb 19; 35(1):3-10. PubMed ID: 8645878 [Abstract] [Full Text] [Related]
20. AGN 191976: a novel thromboxane A2-mimetic with ocular hypotensive properties. Krauss AH, Woodward DF, Chen J, Gibson LL, Lai RK, Protzman CE, Shan T, Williams LS, Gac TS, Burk RM. J Ocul Pharmacol Ther; 1995 Feb 19; 11(3):203-12. PubMed ID: 8590251 [Abstract] [Full Text] [Related] Page: [Next] [New Search]